Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes
Table 1
Characteristics of patients with progression of diabetic nephropathy.
Progression of nephropathy
values
No ()
Yes ()
Male sex (n, %)
67, 47.5
8, 40.0
0.528
Age (years)
0.951
BMI (kg/m2)
0.206
Waist circumference (cm)
0.464
Duration of diabetes (years)
0.158
Treatment of diabetes; diet/OHA/insulin (%)
32.6/51.1/16.3
25.0/50.0/25.0
0.766
Hypertension; CCB/RASi/diuretics (%)
34.8/44.3/4.3
45.0/30.0/10.0
0.357
FPG (mg/dL)
0.037
SD-FPG (mg/dL)
0.040
PMPG (mg/dL)
0.172
SD-PMPG (mg/dL)
0.424
HbA1c (%)
0.004
SD-HbA1c (%)
0.116
Total cholesterol (mg/dL)
0.489
HDL cholesterol (mg/dL)
0.499
LDL cholesterol (mg/dL)
0.995
FTG (mg/dL)
0.005
SD-FTG (mg/dL)
0.037
PMTG (mg/dL)
0.001
SD-PMTG (mg/dL)
0.001
Urinary ACR (mg/g)
0.531
Microalbuminuria (n, %)
36, 25.5
9, 45.0
0.069
Serum creatinine (mg/dL)
0.156
eGFR (mL/min/1.73 m2)
0.971
eGFR < 60 mL/min/1.73 m2 (n, %)
23, 16.3
2, 10.0
0.466
Uric acid (mg/dL)
5.6±0.4
0.149
Systolic BP (mmHg)
0.344
SD-systolic BP (mmHg)
0.934
Diastolic BP (mmHg)
0.816
Mean ± SE unless otherwise stated. OHA: oral hypoglycemic agents, CCB: calcium channel blockers, RASi: renin-angiotensin system inhibitors, PG: plasma glucose, SD: standard deviation, eGFR: estimated glomerular filtration rate, BP: blood pressure, ACR: albumin/creatinine ratio.
